STAAR Surgical Company

NASDAQ:STAA

Medical - Instruments & Supplies

Healthcare
$25.35 -1.37%

-$0.40 today

Market cap
$1.27B
Beta
1.23
P/E (TTM)
-68.3
EPS (TTM)
-$0.42
52W Low $15.59High $35.87

Volume 0.45M

Average 1.07M

STAA Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

STAAR Surgical CompanyNASDAQ: STAA

Selling, General & Admin · Q1 FY2026 · quarter ended Apr 2026

Selling, general & admin declines year over year

Q1 FY2026 selling, general & admin of $40.4M fell 17.7% year over year, behind the -11.1% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 11.1% from the prior quarter. Over 3 fiscal years it compounded at +9.5% a year.

Context

  • Selling, general & admin amounted to 78.6% of revenue in FY2025, up 15.5 pp from a year earlier.
  • Selling, general & admin increased in 2 of the last 3 fiscal years.

What to watch

Whether selling, general & admin reaches the consensus estimate from 7 analysts of $201.48M (+7.0%) for the fiscal year ending Jan 2027, a step up from the -5.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterApr 2026
$40.4M-11.1% QoQ
Last fiscal yearJan 2026
$188.31M-5.0% YoY
LTMApr 2026
$177.31M-11.1% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-17.7%+13.7%+31.4 pp
1 year-5.0%+7.0%+12.0 pp
3-year CAGR+9.5%+8.2%-1.3 pp
5-year CAGR+9.6%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
188.31M USD
Year-over-year change
-5.0%
4-year CAGR
+14.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How STAA compares with its peers on the latest reported figures

  • STAA's LTM Apr 2026 selling, general & admin of $177.31M is the 4th highest of the 5 companies compared; the peer median is $2.06B.
  • Its year-over-year change of -11.1% is the lowest of 5, against a peer median of +8.6%.
  • Selling, general & admin amounts to 61.1% of revenue for STAA, versus a peer median of 43.2%.
STAA Competitors Peer median
Selling, General & Admin for STAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$3.64B +8.6%+4.0%33.3%
BLCOBausch + Lomb CorporationLTM Jun 2026$2.22B +1.8%+14.8%41.8%
COOThe Cooper Companies, Inc.LTM Jul 2026$1.89B +17.9%+6.6%44.5%
STAASTAAR Surgical CompanyLTM Apr 2026$177.31M -11.1%+9.5%61.1%
RXSTRxSight, Inc.LTM Mar 2026$115.87M +8.5%+24.3%90.9%
Peer median (excluding STAA) $2.06B+8.6%+10.7%43.2%

Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue230.47M284.39M322.42M313.9M239.44M
Cost of Revenue51.84M61.01M69.76M74.32M57.02M
Gross Profit178.64M223.38M252.65M239.58M182.42M
Gross Margin77.5%78.5%78.4%76.3%76.2%
Research & Development33.86M35.98M44.4M53.97M40.06M
Selling, General & Admin111.44M143.6M180.15M198.22M188.31M
Operating Expenses145.3M179.58M224.55M252.19M228.37M
Depreciation & Amortization3.64M4.51M5.12M6.89M8.73M
EBITDA34.98M50.06M38.82M(2.16M)(73.54M)
EBITDA Margin15.2%17.6%12.0%-0.7%-30.7%
Operating Income33.34M43.8M28.1M(12.61M)(45.95M)
Operating Margin14.5%15.4%8.7%-4.0%-19.2%
Interest Income—2.45M6.99M5.91M4.59M
Interest Expense38K0000
Other Income / Expenses(2.04M)1.75M5.6M3.56M(36.32M)
Income Before Tax31.3M45.55M33.7M(9.05M)(82.26M)
Pre-Tax Margin13.6%16.0%10.5%-2.9%-34.4%
Income Tax Expense3.79M5.89M12.35M11.16M(1.82M)
Net Income27.51M39.67M21.35M(20.21M)(80.45M)
Net Margin11.9%13.9%6.6%-6.4%-33.6%
EPS (Basic)0.520.830.44(0.41)(1.62)
EPS (Diluted)0.500.800.43(0.41)(1.62)
Weighted Avg Shares47.21M47.99M48.52M49.13M49.57M
Weighted Avg Shares (Diluted)49.46M49.38M49.43M49.13M49.57M

STAAR Surgical Company

NASDAQ:STAA

Intrinsic Alpha fair value

Locked

Current Price

$25.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.